Insulin Degludec + Liraglutide
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Insulin Degludec
insulin-degludec - Liraglutide
liraglutide
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| XULTOPHYCAESEUMX | 100 IU / 3.6 mg / 100 unit | Novo Nordisk A/S |
| Xultophy 100/3.6US | 3.6 mg | Novo Nordisk |
| insulin degludec and liraglutideUS | 3.6 mg | Novo Nordisk |
| Xultophy 100units/ml / 3.6mg/ml solution for injection 3ml pre-filled pensGB | 3.6 mg / 3 mL | Novo Nordisk Ltd |
| Insulin degludec 100units/ml / Liraglutide 3.6mg/ml solution for injection 3ml pre-filled disposable devicesGB | 3.6 mg / 3 mL | Novo Nordisk Ltd |
| insulina degludec + liraglutidaES | 100 IU / 3.6 mg | Novo Nordisk A/S |
| insulin-degludec + liraglutideES | 100 IU / 3.6 mg | Novo Nordisk A/S |
| XULTOPHY SOLUTION FOR INJECTION IN A PRE-FILLED PEN 100 UNITS/ML +3.6MG/MLHK | — | NOVO NORDISK HONG KONG LIMITED |
| XULTOPHY SOLUTION FOR INJECTION IN PRE-FILLED PEN 100 UNITS/ML + 3.6MG/MLHK | — | NOVO NORDISK HONG KONG LIMITED |
| XULTOPHY insulin degludec 100 units/mL liraglutide 3.6 mg/mL solution for injection/pre-filled pen 3 mLAU | 100 U/mL / 3.6 U/mL | Novo Nordisk Pharmaceuticals Pty Ltd |
Same combination in other markets
No product with this combination is recorded in the other covered markets yet.
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.